<DOC>
	<DOCNO>NCT00651963</DOCNO>
	<brief_summary>Gather additional efficacy safety ( pharmacovigilance ) information usual daily care patient Dyslipidemia ezetimibe real condition Colombia associate statin .</brief_summary>
	<brief_title>Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia ( 0653-141 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>&gt; 18 year old Lipid Metabolic Disorder Per ATP III reach goal statin least 4 week Or require LDL reduction Over 50 % reach ATP III goal need statin accordance risk score Pregnancy , Breast Feeding Moderate/Sever Liver Disease : Child Score &gt; Or = To 7 Fibrates Terminal Disease Contraindications To Receive ezetimibe Contraindications To Receive Statins Mental Disability Hypersensitivity To ezetimibe On another Clinical Research Trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>